Jia Yuming, Li Shengchao, Zhang Meng, Zhang Zhilei, Wang Chao, Zhang Chong, Yang Wuhan, Peng Li, Xu Zhuo
Department of Hepatobiliary Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050035, Hebei, People's Republic of China.
Cancer Manag Res. 2021 Jan 13;13:337-349. doi: 10.2147/CMAR.S275003. eCollection 2021.
Hepatocellular carcinoma (HCC) is a horrible malignancy derived from liver. Circular RNAs (circRNAs) act important roles in the pathogenesis and progression of human diseases, including HCC. The current assay intended to investigate the function of circRNA low-density lipoprotein receptor (circ_LDLR) in HCC and clarify the underlying mechanism.
Expression of circ_LDLR, microRNA (miR)-7 and ring finger protein 38 (RNF38) was determined by quantitative real-time PCR (qRT-PCR) or Western blot analysis. Flow cytometry was used to detect cell cycle distribution and apoptosis. Cell colony formation ability and viability were examined by colony formation and methyl thiazolyl tetrazolium (MTT) assays, respectively. Levels of cell proliferation and epithelia-mesenchymal transition (EMT) biomarker proteins were analyzed via Western blot assay. Cell migration and invasion were monitored by Transwell assay, and target relationship between miR-7 and circ_LDLR or RNF38 was validated by dual-luciferase reporter assay. Xenograft model was established to explore the role of circ_LDLR in vivo.
Expression of circ_LDLR and RNF38 was upregulated, but miR-7 expression was downregulated in HCC tissues and cells. Circ_LDLR knockdown significantly inhibited cell proliferation, migration, invasion and EMT in HCC cells. Circ_LDLR acted as a sponge of miR-7, and interference of miR-7 could attenuate circ_LDLR knockdown-induced inhibitory effects on malignant behaviors of HCC cells. Besides, miR-7 also repressed cell proliferation and metastasis of HCC cells, by targeting RNF38. Depletion of circ_LDLR could suppress tumor growth in vivo.
Depletion of circ_LDLR restrained HCC cell proliferation, metastasis and tumorigenesis through the regulation on miR-7/RNF38 axis, affording a promising therapeutic target for HCC.
肝细胞癌(HCC)是一种源自肝脏的恶性肿瘤。环状RNA(circRNAs)在包括HCC在内的人类疾病的发病机制和进展中发挥重要作用。本研究旨在探讨环状低密度脂蛋白受体(circ_LDLR)在HCC中的功能,并阐明其潜在机制。
通过定量实时聚合酶链反应(qRT-PCR)或蛋白质免疫印迹分析来测定circ_LDLR、微小RNA(miR)-7和环指蛋白38(RNF38)的表达。采用流式细胞术检测细胞周期分布和凋亡情况。分别通过集落形成实验和甲基噻唑基四氮唑(MTT)实验检测细胞集落形成能力和活力。通过蛋白质免疫印迹分析检测细胞增殖和上皮-间质转化(EMT)生物标志物蛋白的水平。采用Transwell实验监测细胞迁移和侵袭情况,并通过双荧光素酶报告基因实验验证miR-7与circ_LDLR或RNF38之间的靶向关系。建立异种移植模型以探讨circ_LDLR在体内的作用。
在HCC组织和细胞中,circ_LDLR和RNF38的表达上调,但miR-7的表达下调。敲低circ_LDLR可显著抑制HCC细胞的增殖、迁移、侵袭和EMT。Circ_LDLR作为miR-7的海绵,干扰miR-7可减弱circ_LDLR敲低对HCC细胞恶性行为的抑制作用。此外,miR-7还通过靶向RNF38抑制HCC细胞的增殖和转移。敲低circ_LDLR可抑制体内肿瘤生长。
敲低circ_LDLR通过调节miR-7/RNF38轴抑制HCC细胞的增殖、转移和肿瘤发生,为HCC提供了一个有前景的治疗靶点。